SEC Filings

Form DEF 14A
PROTAGONIST THERAPEUTICS, INC filed this Form DEF 14A on 04/24/2017
Document Outline
Entire Document (323.1 KB)
Subdocument 1 - DEF 14A - DEFINITIVE PROXY STATEMENT
Page 1 - SCHEDULE 14A INFORMATION
Page 2 - NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
Page 3 - PROXY STATEMENT
Page 4 - What am I voting on?
Page 5 - Beneficial Owner: Shares Registered in the Name of Broker or Bank
Page 6 - Can I change my vote after submitting my proxy?
Page 7 - How many votes are needed to approve each proposal?
Page 8 - PROPOSAL 1
Page 9 - THE BOARD OF DIRECTORS RECOMMENDS
Page 10 - CLASS III DIRECTORS CONTINUING IN OFFICE UNTIL THE 2019 ANNUAL MEETING
Page 11 - BOARD LEADERSHIP STRUCTURE
Page 12 - INFORMATION REGARDING COMMITTEES OF THE BOARD OF DIRECTORS
Page 13 - Report of the Audit Committee of the Board of Directors1
Page 14 - Compensation Committee Processes and Procedures
Page 15 - N/A
Page 16 - Compensation Committee Interlocks and Insider Participation
Page 17 - STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS
Page 18 - PROPOSAL 2
Page 19 - PRE-APPROVAL POLICIES AND PROCEDURES
Page 20 - EXECUTIVE OFFICERS
Page 21 - William Hodder
Page 22 - SECURITY OWNERSHIP OF
Page 23 - N/A
Page 24 - SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Page 25 - EXECUTIVE COMPENSATION
Page 26 - NARRATIVE TO SUMMARY COMPENSATION TABLE
Page 27 - OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END
Page 28 - 401(K) PLAN
Page 29 - DIRECTOR COMPENSATION
Page 30 - N/A
Page 31 - TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION
Page 32 - Series C Preferred Stock Financing
Page 33 - INDEMNIFICATION
Page 34 - HOUSEHOLDING OF PROXY MATERIALS
Page 35 - OTHER MATTERS
Page 36 - THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
Page 37 - Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: